COMPARISON OF LAMA/LABA AND ICS/LABA AS INITIAL TREATMENT FOR COPD [PDF]
Respirology, 2019 openaire +1 more source
Worsening Asthma Outcomes in Australian Adults: A Comparison of Stratified Sample Surveys in 2012 and 2021. [PDF]
Med J AustReddel HK +6 more
europepmc +1 more source
Quantifying selection bias due to unobserved patients in pharmacoepidemiologic studies of severe COVID-19 cohorts. [PDF]
BMC Med Res MethodolBokern M +4 more
europepmc +1 more source
Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA adverse event reporting system database. [PDF]
Front Cardiovasc MedLan Y, Hu D, Huang S, Xu M, He Q.
europepmc +1 more source
The Future of New Inhaled Phosphodiesterase Inhibitors in Chronic Obstructive Pulmonary Disease. [PDF]
Open Respir ArchAnzueto A.
europepmc +1 more source
Biologic Switching in Patients with Severe Asthma: Effects on Exacerbations, Corticosteroid Use and Lung Function. [PDF]
J Clin MedDindar Çelik F, Aksu K.
europepmc +1 more source
FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up from Dual Therapy Stratified by Exacerbations and Prior Dual Therapy: A Subgroup Analysis of a Comparative Effectiveness Study. [PDF]
Adv TherWedzicha JA +9 more
europepmc +1 more source
Effects of Inhaled Corticosteroids and Long-Acting β2-Agonists on Efferocytosis and Inflammatory Cell Survival: An In Vitro Study Relevant to COPD and Lung Cancer. [PDF]
Int J Mol SciRedwan B +4 more
europepmc +1 more source
Reported use of anti-asthmatic medication in doping control forms from 2015 to 2019 - mapping retrospective data. [PDF]
Front Sports Act LivingKojen AJ +5 more
europepmc +1 more source